Bausch + Lomb Corporation
BLCO.TOTSXHealthcare● Active
$21.10
$-0.54(-2.50%)
Market Cap$7.5B
P/E Ratio—
52W High$25.7
52W Low$15.69
Bausch + Lomb Corporation (BLCO.TO) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BLCO.TO · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.36B) | ($0.30B) | ($0.25B) | $0.01B | $0.19B |
| Depreciation & Amort. | $0.42B | $0.44B | $0.38B | $0.38B | $0.41B |
| Stock-Based Comp. | $0.00B | $0.09B | $0.07B | $0.06B | $0.06B |
| Change in Working Capital | $0.02B | ($0.09B) | ($0.29B) | ($0.02B) | $0.03B |
| Net Cash from Operations | $0.28B | $0.23B | ($0.02B) | $0.34B | $0.87B |
| Investing Activities | |||||
| Capital Expenditure | ($0.35B) | ($0.29B) | ($0.18B) | ($0.17B) | ($0.21B) |
| Purchases of Investments | ($0.13B) | ($0.01B) | ($0.02B) | ($0.06B) | ($0.02B) |
| Sales of Investments | $0.01B | $0.01B | $0.02B | $0.02B | $0.01B |
| Net Cash from Investing | ($0.45B) | ($0.41B) | ($2.11B) | ($0.21B) | ($0.21B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | ($0.01B) | ($0.01B) | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.25B | $0.20B | $2.12B | $2.46B | $0.00B |
| Net Cash from Financing | $0.22B | $0.18B | $2.08B | $0.08B | ($0.71B) |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.07B) | ($0.06B) | ($0.20B) | $0.17B | $0.66B |
| FCF Margin %(computed) | -1.29% | -1.23% | -4.78% | 4.51% | 17.64% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Bausch + Lomb Corporation data
About Bausch + Lomb Corporation (BLCO.TO) Cash Flow Statement
Bausch + Lomb Corporation generated operating cash flow of $0.28B and free cash flow of ($0.07B) for 2025 — a FCF margin of -1.29%. Capital expenditure was ($0.35B).
Frequently asked questions
BLCO.TO · 4 questionsBausch + Lomb Corporation generated free cash flow of ($0.07B) for 2025, down 11.9% year-over-year.
BLCO.TO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10